These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 1003526

  • 1. Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma.
    Mavligit GM, Gutterman JU, Hersh EM.
    J Natl Cancer Inst; 1976 Oct; 57(4):749-51. PubMed ID: 1003526
    [Abstract] [Full Text] [Related]

  • 2. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
    Cohen MH, Jessup JM, Felix EL, Weese JL, Herberman RB.
    Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
    [Abstract] [Full Text] [Related]

  • 3. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
    Djawari D, Körner E, Haneke E.
    Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
    [Abstract] [Full Text] [Related]

  • 4. A technique for intensifying BCG sensitivity.
    Parmett SR, Klein E.
    J Med; 1975 Apr; 6(3-4):213-6. PubMed ID: 1104733
    [Abstract] [Full Text] [Related]

  • 5. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM, Cerni C, Micksche M.
    Oncology; 1977 Apr; 34(5):229-33. PubMed ID: 917456
    [Abstract] [Full Text] [Related]

  • 6. [Immunotherapy of malignant melanoma (active specific and non-specific immune stimulation) (author's transl)].
    Kokoschka EM, Micksche M.
    Wien Klin Wochenschr; 1976 Nov 12; 88(21):690-6. PubMed ID: 1007279
    [Abstract] [Full Text] [Related]

  • 7. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S, Haftek M, Sliński W.
    Dermatologica; 1977 Nov 12; 155(1):13-25. PubMed ID: 303184
    [Abstract] [Full Text] [Related]

  • 8. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
    Cassimos C, Kanakoudi-Tsakalidis F, Spyroglou K, Ladianos M, Tzaphi R.
    J Clin Lab Immunol; 1980 Mar 12; 3(2):111-3. PubMed ID: 7205930
    [Abstract] [Full Text] [Related]

  • 9. DNCB reactivity and prognosis in 419 patients with malignant melanoma.
    Camacho ES, Pinsky CM, Braun DW, Golbey RB, Fortner JG, Wanebo HJ, Oettgen HF.
    Cancer; 1981 May 15; 47(10):2446-50. PubMed ID: 7272900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of murine tumors on delayed hypersensitivity to dinitrochlorobenzene. I. Description of anergy caused by transplanted tumors.
    Jessup JM, Cohen MH, Tomaszewski MM, Felix EL.
    J Natl Cancer Inst; 1976 Nov 15; 57(5):1077-84. PubMed ID: 1003543
    [Abstract] [Full Text] [Related]

  • 12. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B, Wätzig V, Knöll B.
    Arch Geschwulstforsch; 1978 Nov 15; 48(8):722-8. PubMed ID: 753194
    [Abstract] [Full Text] [Related]

  • 13. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
    Trapeznikov NN, Iavorskiĭ VV, Kadagidze ZG, Malaev SG, Kupin VI.
    Vopr Onkol; 1977 Nov 15; 23(8):27-33. PubMed ID: 906404
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. BCG in cancer therapy: theoretical bases of immunotherapy.
    Dodd MJ.
    Am J Nurs; 1979 Feb 15; 79(2):310-4. PubMed ID: 311587
    [No Abstract] [Full Text] [Related]

  • 16. Adoptive transfer and specific active immunization of patients with malignant melanoma.
    Seigler H, Buckley CE, Sheppard LB, Horne BJ, Shingleton WW.
    Ann N Y Acad Sci; 1976 Feb 15; 277(00):522-32. PubMed ID: 1069561
    [No Abstract] [Full Text] [Related]

  • 17. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
    Bürkle PA, Tönnesmann E, Ahnefeld S, Nobbe F, Federlin K.
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr 15; 151(2):153-65. PubMed ID: 134535
    [Abstract] [Full Text] [Related]

  • 18. [2,4-dinitrochlorobenzene (DNCB) in the study of delayed hypersensitivity in some infectious diseases].
    Cirelli A, D'Amato C, Lanzalone CM.
    Boll Soc Ital Biol Sper; 1974 Aug 15; 50(15):1157-62. PubMed ID: 4549182
    [No Abstract] [Full Text] [Related]

  • 19. [Activity of 2,4 dinitrochlorbenzene skin tests during the course of immunotherapy of malignant melanomas].
    Richter J, Duchková H, Kubíková M.
    Cas Lek Cesk; 1975 Sep 26; 114(39):1201-3. PubMed ID: 1182748
    [No Abstract] [Full Text] [Related]

  • 20. Sequential evaluation of general immune competence in cancer patients: correlation with clinical course.
    Eilber FR, Nizze JA, Morton DL.
    Cancer; 1975 Mar 26; 35(3):660-5. PubMed ID: 234294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.